{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:36:18Z","timestamp":1782869778031,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T00:00:00Z","timestamp":1474848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coxsackievirus A16 (CA16) is one of the major pathogens associated with human hand, foot, and mouth disease (HFMD) in the Asia-pacific region. Although CA16 infections are generally mild, severe neurological manifestations or even death has been reported. Studies on CA16 pathogenesis and vaccine development are severely hampered because the small animal models that are currently available show major limitations. In this study, gerbils (<jats:italic>Meriones unguiculatus<\/jats:italic>) were investigated for their suitability as an animal model to study CA16 pathogenesis and vaccine development. Our results showed that gerbils up to the age of 21 days were fully susceptible to CA16 and all died within five days post-infection. CA16 showed a tropism towards the skeletal muscle, spinal cord and brainstem of gerbils, and severe lesions, including necrosis, were observed. In addition, an inactivated CA16 whole-virus vaccine administrated to gerbils was able to provide full protection to the gerbils against lethal doses of CA16 strains. These results demonstrate that gerbils are a suitable animal model to study CA16 infection and vaccine development.<\/jats:p>","DOI":"10.1038\/srep34299","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T08:54:57Z","timestamp":1474880097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Coxsackievirus A16 induced neurological disorders in young gerbils which could serve as a new animal model for vaccine evaluation"],"prefix":"10.1038","volume":"6","author":[{"given":"Yi-Sheng","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Nv","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ping","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Feng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Hong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ping","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,26]]},"reference":[{"key":"BFsrep34299_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.antiviral.2016.02.011","volume":"129","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice. Antiviral. Res. 129, 47\u201351 (2016).","journal-title":"Antiviral. Res."},{"key":"BFsrep34299_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","volume":"199","author":"HF Rabenau","year":"2010","unstructured":"Rabenau, H. F., Richter, M. & Doerr, H. W. Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med. Microbiol. Immunol. 199, 45\u201351 (2010).","journal-title":"Med. Microbiol. Immunol."},{"key":"BFsrep34299_CR3","first-page":"959","volume":"57","author":"SH Park","year":"2011","unstructured":"Park, S. H. et al. Detection and characterization of enterovirus associated with herpangina and hand, foot, and mouth disease in Seoul, Korea. Clin. Lab. 57, 959\u2013967 (2011).","journal-title":"Clin. Lab."},{"key":"BFsrep34299_CR4","first-page":"254","volume":"62","author":"M Iwai","year":"2009","unstructured":"Iwai, M. et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn. J. Infect. Dis. 62, 254\u2013259 (2009).","journal-title":"Jpn. J. Infect. Dis."},{"key":"BFsrep34299_CR5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","volume":"38","author":"LW Ang","year":"2009","unstructured":"Ang, L. W. et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007. Ann. Acad. Med. Singapore 38, 106\u2013112 (2009).","journal-title":"Ann. Acad. Med. Singapore"},{"key":"BFsrep34299_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/rmv.1827","volume":"25","author":"SL Liu","year":"2015","unstructured":"Liu, S. L. et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev. Med. Virol. 25, 115\u2013128 (2015).","journal-title":"Rev. Med. Virol."},{"key":"BFsrep34299_CR7","doi-asserted-by":"publisher","first-page":"e96051","DOI":"10.1371\/journal.pone.0096051","volume":"9","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China. PLoS One. 9, e96051 (2014).","journal-title":"PLoS One"},{"key":"BFsrep34299_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","volume":"23","author":"CY Wang","year":"2004","unstructured":"Wang, C. Y. et al. Fatal coxsackievirus A16 infection. Pediatr Infect. Dis. J. 23, 275\u2013276 (2004).","journal-title":"Pediatr Infect. Dis. J."},{"key":"BFsrep34299_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3201\/eid1307.070295","volume":"13","author":"F Legay","year":"2007","unstructured":"Legay, F. et al. Fatal coxsackievirus A-16 pneumonitis in adult. Emerg. Infect. Dis. 13, 1084\u20131086 (2007).","journal-title":"Emerg. Infect. Dis."},{"key":"BFsrep34299_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","volume":"268","author":"HT Wright Jr.","year":"1963","unstructured":"Wright, H. T. Jr., Landing, B. H., Lennette, E. H. & Mc, A. R. Fatal infection in an infant associated with Coxsackie virus group A, type 16. N. Engl. J. Med. 268, 1041\u20131044 (1963).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep34299_CR11","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3201\/eid1510.090594","volume":"15","author":"K Goto","year":"2009","unstructured":"Goto, K. et al. Rhombencephalitis and coxsackievirus A16. Emerg. Infect. Dis. 15, 1689\u20131691 (2009).","journal-title":"Emerg. Infect. Dis."},{"key":"BFsrep34299_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/00365548.2011.634433","volume":"44","author":"XF Yan","year":"2012","unstructured":"Yan, X. F. et al. Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis. 44, 297\u2013305 (2012).","journal-title":"Scand J Infect Dis."},{"key":"BFsrep34299_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1086\/511073","volume":"44","author":"MH Ooi","year":"2007","unstructured":"Ooi, M. H. et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 44, 646\u2013656 (2007).","journal-title":"Clin Infect Dis"},{"key":"BFsrep34299_CR14","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.vaccine.2014.03.012","volume":"32","author":"Y Cai","year":"2014","unstructured":"Cai, Y. et al. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine 32, 2406\u20132412 (2014).","journal-title":"Vaccine"},{"key":"BFsrep34299_CR15","doi-asserted-by":"crossref","unstructured":"Mao, Q. Y. et al. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev. Vaccines 1\u20138 (2016).","DOI":"10.1586\/14760584.2016.1138862"},{"key":"BFsrep34299_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","volume":"381","author":"FC Zhu","year":"2013","unstructured":"Zhu, F. C. et al. Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet. 381, 1037\u20131045 (2013).","journal-title":"Lancet"},{"key":"BFsrep34299_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1099\/vir.0.063560-0","volume":"95","author":"J Li","year":"2014","unstructured":"Li, J. et al. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J. Gen. Virol. 95, 1083\u20131093 (2014).","journal-title":"J. Gen. Virol."},{"key":"BFsrep34299_CR18","doi-asserted-by":"publisher","first-page":"11967","DOI":"10.1128\/JVI.00902-12","volume":"86","author":"Q Mao","year":"2012","unstructured":"Mao, Q. et al. A neonatal mouse model of coxsackievirus A16 for vaccine evaluation. J. Virol. 86, 11967\u201311976 (2012).","journal-title":"J. Virol."},{"key":"BFsrep34299_CR19","doi-asserted-by":"crossref","unstructured":"Ku, Z. et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine (2014).","DOI":"10.1016\/j.vaccine.2014.06.025"},{"key":"BFsrep34299_CR20","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","volume":"31","author":"Y Cai","year":"2013","unstructured":"Cai, Y. et al. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine. 31, 2215\u20132221 (2013).","journal-title":"Vaccine"},{"key":"BFsrep34299_CR21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/iai.43.1.43-48.1984","volume":"43","author":"GW Jeffers","year":"1984","unstructured":"Jeffers, G. W., Klei, T. R. & Enright, F. M. Activation of jird (Meriones unguiculatus) macrophages by the filarial parasite Brugia pahangi. Infect Immun. 43, 43\u201348 (1984).","journal-title":"Infect Immun."},{"key":"BFsrep34299_CR22","first-page":"760","volume":"99","author":"ZY Zhu","year":"1986","unstructured":"Zhu, Z. Y., Yao, S. R., Fu, G. M. & Weng, J. Q. Propagation of epidemic hemorrhagic fever virus in Meriones unguiculatus. Chin. Med. J. 99, 760\u2013762 (1986).","journal-title":"Chin. Med. J."},{"key":"BFsrep34299_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1756-3305-7-43","volume":"7","author":"S Arumugam","year":"2014","unstructured":"Arumugam, S. et al. Vaccination with recombinant Brugia malayi cystatin proteins alters worm migration, homing and final niche selection following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae. Parasit Vectors 7, 43 (2014).","journal-title":"Parasit Vectors"},{"key":"BFsrep34299_CR24","doi-asserted-by":"publisher","first-page":"e51996","DOI":"10.1371\/journal.pone.0051996","volume":"7","author":"PP Yao","year":"2012","unstructured":"Yao, P. P. et al. Enterovirus 71-induced neurological disorders in young gerbils, Meriones unguiculatus: development and application of a neurological disease model. PLoS One 7, e51996 (2012).","journal-title":"PLoS One"},{"key":"BFsrep34299_CR25","unstructured":"Wang, X. G. et al. Study on immunogenicity in mice induced by inactivated EV71 and CAl6 bivalent vaccine. Prog in Microbiol. Immunol. 42 (2014)."},{"key":"BFsrep34299_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1128\/JCM.02338-09","volume":"48","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol. 48, 619\u2013622 (2010).","journal-title":"J Clin Microbiol"},{"key":"BFsrep34299_CR27","doi-asserted-by":"publisher","first-page":"e0119173","DOI":"10.1371\/journal.pone.0119173","volume":"10","author":"F Xu","year":"2015","unstructured":"Xu, F. et al. Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS One 10, e0119173 (2015).","journal-title":"PLoS One"},{"key":"BFsrep34299_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1743-422X-8-106","volume":"8","author":"JF Han","year":"2011","unstructured":"Han, J. F. et al. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo . Virol. J. 8, 106 (2011).","journal-title":"Virol. J."},{"key":"BFsrep34299_CR29","doi-asserted-by":"publisher","first-page":"e2599","DOI":"10.1371\/journal.pntd.0002599","volume":"7","author":"M Zeng","year":"2013","unstructured":"Zeng, M. et al. The cytokine and chemokine profiles in patients with hand, foot and mouth disease of different severities in Shanghai, China, 2010. PLoS Negl Trop Dis. 7, e2599 (2013).","journal-title":"PLoS Negl Trop Dis"},{"key":"BFsrep34299_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1186\/1471-2334-13-606","volume":"13","author":"X Zhang","year":"2013","unstructured":"Zhang, X. et al. Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China. BMC Infect Dis. 13, 606 (2013).","journal-title":"BMC Infect Dis"},{"key":"BFsrep34299_CR31","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/00006454-199912000-00013","volume":"18","author":"LY Chang","year":"1999","unstructured":"Chang, L. Y. et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 18, 1092\u20131096 (1999).","journal-title":"Pediatr Infect Dis J."},{"key":"BFsrep34299_CR32","doi-asserted-by":"publisher","first-page":"e111174","DOI":"10.1371\/journal.pone.0111174","volume":"9","author":"Z Li","year":"2014","unstructured":"Li, Z. et al. Coxsackievirus a16 infection induces neural cell and non-neural cell apoptosis in vitro . PLoS One 9, e111174 (2014).","journal-title":"PLoS One"},{"key":"BFsrep34299_CR33","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.3390\/v6072778","volume":"6","author":"L Xu","year":"2014","unstructured":"Xu, L. et al. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruses 6, 2778\u20132795 (2014).","journal-title":"Viruses"},{"key":"BFsrep34299_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12272-014-0390-9","volume":"38","author":"SG Yeo","year":"2015","unstructured":"Yeo, S. G. et al. Antiviral effects of Phyllanthus urinaria containing corilagin against human enterovirus 71 and Coxsackievirus A16 in vitro . Arch. Pharm. Res. 38, 193\u2013202 (2015).","journal-title":"Arch. Pharm. Res."},{"key":"BFsrep34299_CR35","doi-asserted-by":"publisher","first-page":"7916","DOI":"10.1128\/JVI.78.15.7916-7924.2004","volume":"78","author":"YF Wang","year":"2004","unstructured":"Wang, Y. F. et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 78, 7916\u20137924 (2004).","journal-title":"J Virol"},{"key":"BFsrep34299_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/JVI.00999-09","volume":"84","author":"KC Ong","year":"2010","unstructured":"Ong, K. C., Devi, S., Cardosa, M. J. & Wong, K. T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 84, 661\u2013665 (2010).","journal-title":"J Virol"},{"key":"BFsrep34299_CR37","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.micinf.2011.04.004","volume":"13","author":"W Wang","year":"2011","unstructured":"Wang, W. et al. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect. 13, 862\u2013870 (2011).","journal-title":"Microbes Infect"},{"key":"BFsrep34299_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virusres.2012.04.009","volume":"167","author":"Z Zaini","year":"2012","unstructured":"Zaini, Z., Phuektes, P. & McMinn, P. Mouse adaptation of a sub-genogroup B5 strain of human enterovirus 71 is associated with a novel lysine to glutamic acid substitution at position 244 in protein VP1. Virus Res. 167, 86\u201396 (2012).","journal-title":"Virus Res"},{"key":"BFsrep34299_CR39","first-page":"449","volume":"46","author":"S Owatanapanich","year":"2015","unstructured":"Owatanapanich, S., Wutthanarungsan, R., Jaksupa, W. & Thisyakorn, U. Risk Factors for Severe Hand, Foot and Mouth Disease. Southeast Asian J Trop Med Public Health 46, 449\u2013459 (2015).","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"BFsrep34299_CR40","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1002\/jmv.24275","volume":"87","author":"X Yao","year":"2015","unstructured":"Yao, X. et al. Enterovirus spectrum from the active surveillance of hand foot and mouth disease patients under the clinical trial of inactivated Enterovirus A71 vaccine in Jiangsu, China, 2012\u20132013. J. Med. Virol. 87, 2009\u20132017 (2015).","journal-title":"J. Med. Virol."},{"key":"BFsrep34299_CR41","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1038\/emi.2015.12","volume":"4","author":"C Zhang","year":"2015","unstructured":"Zhang, C. et al. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou city, Jiangsu province, China, in 2012\u20132013. Emerg. Microbes Infect. 4, e12 (2015).","journal-title":"Emerg. Microbes Infect."},{"key":"BFsrep34299_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.virusres.2013.10.020","volume":"179","author":"JF Han","year":"2014","unstructured":"Han, J. F. et al. Phenotypic and genomic characterization of human coxsackievirus A16 strains with distinct virulence in mice. Virus Res. 179, 212\u2013219 (2014).","journal-title":"Virus Res"},{"key":"BFsrep34299_CR43","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","volume":"32","author":"Z Ku","year":"2014","unstructured":"Ku, Z. et al. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 32, 4296\u20134303 (2014).","journal-title":"Vaccine"},{"key":"BFsrep34299_CR44","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1016\/j.vaccine.2015.08.016","volume":"33","author":"C Zhang","year":"2015","unstructured":"Zhang, C. et al. Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71. Vaccine 33, 5087\u20135094 (2015).","journal-title":"Vaccine"},{"key":"BFsrep34299_CR45","doi-asserted-by":"publisher","first-page":"6444","DOI":"10.1128\/JVI.00200-14","volume":"88","author":"M Gong","year":"2014","unstructured":"Gong, M. et al. Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development. J. Virol. 88, 6444\u20136452 (2014).","journal-title":"J. Virol."},{"key":"BFsrep34299_CR46","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493\u2013497 (1938).","journal-title":"Am. J. Hyg"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep34299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34299","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep34299.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:48:15Z","timestamp":1672897695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep34299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,26]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep34299"],"URL":"https:\/\/doi.org\/10.1038\/srep34299","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,26]]},"assertion":[{"value":"18 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34299"}}